HungaryHungary

Big backing

04.04.2011

Budapest – Hungarian vaccine developer Genetic Immunity Kft. (GI) has secured a cash injection of US$25m by signing an agreement with the Budapest-based technology commercialisation company Power of the Dream Ventures, Inc. The firm’s CEO Viktor Rozsnyay says that GI will present a road map soon. A specialist for trans­dermally-administered DNA vaccines that activate antigen-presenting cells, GI recently completed a Phase II proof-of-concept study demonstrating clinically significant median 70% viral load reduction in vaccinated HIV patients without systemic side effects as compared to placebo.

HungaryHungary

20.09.2009

Budapest – Mecsek Pharma has won a HUF1bn (EUR3.6m) state grant that will allow the company to test the insulin sensitiser BGT-15 in a Phase IIb clinical trial, according to Mecsek’s parent company Phylaxia Holding. BGT-15 is a...

HungaryHungary

12.09.2009

Budapest – California-based biotech company Codexis plans to expand its expertise in fermentation technology. In August, Codexis’ CEO Alan Shaw announced that the firm will expand its activities in fermentation technology in...

HungaryHungary

13.07.2009

Budapest – UK clinical research organisation Chiltern International Ltd has opened a new office in Budapest. The branch will be led by Dr. Attila Lorinczi , a member of the Hungarian Medical Society and the Society of Hungarian...

HungaryHungary

29.04.2009

Budapest – The European Institute of Innovation and Technology (EIT) launched a call for proposals for its first Knowledge and Innovation Communities (KICs) at the beginning of April (http://eit.europa.eu). The call will remain...

HungaryHungary

05.11.2008

Budapest/Brussels – The Budapest-based European Institute of Technology (EIT, http://eit.europa.eu) has received its first governing board. The 18 members, who held the board’s inaugural meeting on the occasion of the EIT’s...

HungaryHungary

20.10.2008

Debrecen/Budapest – Hungary’s leading pharmaceutical company Gedeon Richter Plc. is continuing to expand its activities in biotechnological R&D and manufacturing of therapeutic proteins. After the establishment of Richter-Helm in...

HungaryHungary

18.08.2008

Budapest/Brussels – The European research ministers decided in mid-June that the Hungarian capital Budapest will house the headquarters of the prestigious European Institute of Technology (EIT). With a budget of EUR308m until...

HungaryHungary

14.08.2008

Geneva – Ernesto Bertarelli, the Swiss-Italian biotech billionaire who sold his company Serono SA, has returned to the front lines of the pharma business as his new EUR1bn healthcare fund joined with Merrill Lynch to buy...

HungaryHungary

20.05.2008

Bucharest – Three years ago, Romania was Europe’s largest cultivator of genetically modified plants (87,600 hectares of GM soy acreage). With acession, the government there had to halt the cultivation of the GM crops not approved...

HungaryHungary

19.03.2008

Zagreb – Pliva d.d., Barr Pharmaceuticals‘ subsidiary in Croatia, is selling its three operations in Spain – Pliva Pharma Iberia, Laboratorios Edigen and Uso Racional – to Biomedica Foscama Industria Chimico-Farmaceutica. For a...

Displaying results 11 to 20 out of 89

< Previous 11-20 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-hungary/browse/1/article/big-backing.html

Events

All Events

Stock list

All quotes

TOP

  • THERAMETRICS0.09 CHF12.50%
  • PAION2.99 EUR11.15%
  • CO.DON3.00 EUR5.63%

FLOP

  • 4SC1.09 EUR-6.03%
  • STRATEC BIOMEDICAL39.80 EUR-3.40%
  • ADDEX3.22 CHF-3.30%

TOP

  • SANTHERA91.65 CHF43.0%
  • CO.DON3.00 EUR26.1%
  • PAION2.99 EUR20.1%

FLOP

  • EVOTEC3.07 EUR-18.1%
  • 4SC1.09 EUR-18.0%
  • MEDIGENE4.06 EUR-14.0%

TOP

  • SANTHERA91.65 CHF1987.7%
  • CO.DON3.00 EUR244.8%
  • PAION2.99 EUR187.5%

FLOP

  • CYTOS0.24 CHF-94.0%
  • 4SC1.09 EUR-43.2%
  • MERCK KGAA67.58 EUR-41.3%

No liability assumed, Date: 15.09.2014


Current issue

All issues

Product of the week

Products